TO COMPARE THE EFFECTS OF LEVENORGESTREL RELEASING INTRAUTERINE SYSTEM AND DEPOT MEDROXYPROGESTERONE ACETATE IN TREATMENT OF HEAVY MENSTRUAL BLEEDING
- Conditions
- Health Condition 1: N850- Endometrial hyperplasiaHealth Condition 2: N921- Excessive and frequent menstruation with irregular cycleHealth Condition 3: N945- Secondary dysmenorrhea
- Registration Number
- CTRI/2023/09/057366
- Lead Sponsor
- ESI MEDICAL COLLEGE, JOKA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All women having heavy menstrual bleeding with or without associated dysmenorrhea or chronic pelvic pain
All women with histologically proven endometrial hyperplasia without atypia or any other benign endometrial pathology
Fibroid uterus <12 weeks not distorting the endometrial cavity
Adenomyosis
Medical or surgical high-risk factors making the subjects unsuitable for surgery
Age group between 30-50 years
Active genital infection
Suspicion of pregnancy, malignancy
Uterine fibroids or submucosal fibroid distorting the endometrial cavity
Atypical endometrial hyperplasia or malignancy
Abnormal cervical cytology and malignancy
Haematological disease, abnormal coagulopathy
Liver disease, uncontrolled diabetes mellitus
H/o arterial or venous thromboembolic disorders
Women who are willing to conceive.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method